These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21148125)

  • 41. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations.
    Karafillakis E; Larson HJ;
    Vaccine; 2017 Sep; 35(37):4840-4850. PubMed ID: 28760616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The next decade of vaccines: societal and scientific challenges.
    Moxon ER; Siegrist CA
    Lancet; 2011 Jul; 378(9788):348-59. PubMed ID: 21664685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating the safety of new vaccines: summary of a workshop.
    Ellenberg SS; Foulkes MA; Midthun K; Goldenthal KL
    Am J Public Health; 2005 May; 95(5):800-7. PubMed ID: 15855455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trust collapse caused by the Changsheng vaccine crisis in China.
    Zhou M; Qu S; Zhao L; Kong N; Campy KS; Wang S
    Vaccine; 2019 Jun; 37(26):3419-3425. PubMed ID: 31097351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Communicating vaccine safety in the context of immunization programs in low resource settings.
    Arwanire EM; Mbabazi W; Mugyenyi P
    Curr Drug Saf; 2015; 10(1):68-75. PubMed ID: 25859678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Communication in crisis situations in the process of immunization.
    Ravlija J; Vasilj I
    Coll Antropol; 2012 Sep; 36(3):1069-73. PubMed ID: 23213975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Relationship between pharmaceutical industry and public health in vaccination].
    Gervasi G; Capanna A; Soncini R; Zaratti L; Franco E
    Ig Sanita Pubbl; 2015; 71(2):225-32. PubMed ID: 26057178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The need to teach vaccine safety to basic scientists and public health officials.
    Khamesipour A
    Curr Drug Saf; 2015; 10(1):76-9. PubMed ID: 25859679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Understanding public perceptions of benefits and risks of childhood vaccinations in the United States.
    Song G
    Risk Anal; 2014 Mar; 34(3):541-55. PubMed ID: 24033739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Understanding those who do not understand: a brief review of the anti-vaccine movement.
    Poland GA; Jacobson RM
    Vaccine; 2001 Mar; 19(17-19):2440-5. PubMed ID: 11257375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk communication of vaccines: challenges in the post-trust environment.
    Bouder F
    Curr Drug Saf; 2015; 10(1):9-15. PubMed ID: 25859669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk perception, risk management and safety assessment: what can governments do to increase public confidence in their vaccine system?
    MacDonald NE; Smith J; Appleton M
    Biologicals; 2012 Sep; 40(5):384-8. PubMed ID: 21993306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Becoming a vaccine champion: evidence-based interventions to address the challenges of vaccination.
    Temoka E
    S D Med; 2013; Spec no():68-72. PubMed ID: 23444594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Building confidence in vaccines.
    Smith JC; Appleton M; MacDonald NE
    Adv Exp Med Biol; 2013; 764():81-98. PubMed ID: 23654058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On pins and needles: how vaccines are portrayed on Pinterest.
    Guidry JP; Carlyle K; Messner M; Jin Y
    Vaccine; 2015 Sep; 33(39):5051-6. PubMed ID: 26319742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccine discovery and translation of new vaccine technology.
    Rappuoli R; Black S; Lambert PH
    Lancet; 2011 Jul; 378(9788):360-8. PubMed ID: 21664687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Why some messages speak better: child immunization in the news and on the internet.
    Rundblad G
    Curr Drug Saf; 2015; 10(1):87-93. PubMed ID: 25859681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Policy making for vaccine use as a driver of vaccine innovation and development in the developed world.
    Seib K; Pollard AJ; de Wals P; Andrews RM; Zhou F; Hatchett RJ; Pickering LK; Orenstein WA
    Vaccine; 2017 Mar; 35(10):1380-1389. PubMed ID: 28253995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Communicating vaccine safety to the media and general public.
    Oubari H; Tuttle R; Rath B; Bravo L
    Curr Drug Saf; 2015; 10(1):80-6. PubMed ID: 25859680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study.
    de Figueiredo A; Simas C; Karafillakis E; Paterson P; Larson HJ
    Lancet; 2020 Sep; 396(10255):898-908. PubMed ID: 32919524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.